메뉴 건너뛰기




Volumn 41, Issue 11, 2003, Pages 499-503

Determination of the pharmacokinetics of cerivastatin when administered in combination with sirolimus and cyclosporin A in patients with kidney transplant, and review of the relevant literature

Author keywords

Cerivastatin; Cyclosporin A; Renal transplantation; Sirolimus; Statins; Tacrolimus

Indexed keywords

CERIVASTATIN; CORTICOSTEROID; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RAPAMYCIN; TACROLIMUS;

EID: 0242606429     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41499     Document Type: Review
Times cited : (9)

References (22)
  • 1
    • 0027377733 scopus 로고
    • Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without cyclosporine
    • Arnadottir M, Eriksson LO, Thysell H, Karkas JD 1993 Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without cyclosporine. Nephrone 65: 410-413
    • (1993) Nephrone , vol.65 , pp. 410-413
    • Arnadottir, M.1    Eriksson, L.O.2    Thysell, H.3    Karkas, J.D.4
  • 2
    • 0035502455 scopus 로고    scopus 로고
    • Bilateral pharmacokinetic interaction between cyclosporin A and atorvastatin in renal transplant recipients
    • Asberg A, Hartmann A, Fjeldsa E, Bergan S, Holdaas H 2001 Bilateral pharmacokinetic interaction between cyclosporin A and atorvastatin in renal transplant recipients. Am J Transplant 1: 382-386
    • (2001) Am. J. Transplant. , vol.1 , pp. 382-386
    • Asberg, A.1    Hartmann, A.2    Fjeldsa, E.3    Bergan, S.4    Holdaas, H.5
  • 4
    • 0031736655 scopus 로고    scopus 로고
    • Metabolism and drug interaction of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar?
    • Christians U, Jacobsen W, Floren SC 1998 Metabolism and drug interaction of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther 80: 1-34
    • (1998) Pharmacol. Ther. , vol.80 , pp. 1-34
    • Christians, U.1    Jacobsen, W.2    Floren, S.C.3
  • 5
    • 0036238215 scopus 로고    scopus 로고
    • Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography mass spectrometry (LC-MS)
    • Deters M, Kirchner G, Resch K, Kaever V 2002 Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography mass spectrometry (LC-MS). Clin Chem Lab Med 40: 285-292
    • (2002) Clin. Chem. Lab. Med. , vol.40 , pp. 285-292
    • Deters, M.1    Kirchner, G.2    Resch, K.3    Kaever, V.4
  • 7
    • 0034808667 scopus 로고    scopus 로고
    • Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus
    • Ichimaru N, Takahara S, Kokado Y, Wang JD, Hatori M, Kameoka H, Inoue T, Okuyama A 2001 Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Atherosclerosis 158: 417-423
    • (2001) Atherosclerosis , vol.158 , pp. 417-423
    • Ichimaru, N.1    Takahara, S.2    Kokado, Y.3    Wang, J.D.4    Hatori, M.5    Kameoka, H.6    Inoue, T.7    Okuyama, A.8
  • 9
    • 0027746271 scopus 로고    scopus 로고
    • LC separation and induced fluorometric detection of cerivastatin in blood samples
    • Krol GJ, Beck GW, Ritter W, Lettieri JT 1999 LC separation and induced fluorometric detection of cerivastatin in blood samples. J Pharm Biomed Anal 11: 1269-1275
    • (1999) J. Pharm. Biomed. Anal. , vol.11 , pp. 1269-1275
    • Krol, G.J.1    Beck, G.W.2    Ritter, W.3    Lettieri, J.T.4
  • 10
    • 0032435677 scopus 로고    scopus 로고
    • Cerivastatin (BAY w 6228): A novel HMG-CoA reductase inhibitor
    • Kuhlmann J, Muck W, Bischoff H et al 1998 Cerivastatin (BAY w 6228): a novel HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 16: 236-263
    • (1998) Cardiovasc. Drug Rev. , vol.16 , pp. 236-263
    • Kuhlmann, J.1    Muck, W.2    Bischoff, H.3
  • 12
    • 0031658907 scopus 로고    scopus 로고
    • Thorough assessment of interaction profile supports safe therapeutic use of statins: Focus on cerivastatin
    • Muck W 1998 Thorough assessment of interaction profile supports safe therapeutic use of statins: focus on cerivastatin. Drugs 56 (Suppl 1): 15-23
    • (1998) Drugs , vol.56 , Issue.SUPPL. 1 , pp. 15-23
    • Muck, W.1
  • 14
    • 0033831429 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of cerivastatin
    • Muck W 2000 Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet 39: 99-116
    • (2000) Clin. Pharmacokinet. , vol.39 , pp. 99-116
    • Muck, W.1
  • 21
    • 0043031113 scopus 로고    scopus 로고
    • Tacrolimus and cerivastatin pharmacokinetics, efficacy and safety after single and multiple dosing of cerivastatin in renal transplant recipients
    • (in press)
    • Renders L, Haas CS, Liebelt J, Oberbarnscheid M, Schöcklmann HO, Kunzendorf U 2003 Tacrolimus and cerivastatin pharmacokinetics, efficacy and safety after single and multiple dosing of cerivastatin in renal transplant recipients. Br J Clin Pharm (in press)
    • (2003) Br. J. Clin. Pharm.
    • Renders, L.1    Haas, C.S.2    Liebelt, J.3    Oberbarnscheid, M.4    Schöcklmann, H.O.5    Kunzendorf, U.6
  • 22
    • 0028606438 scopus 로고
    • Pharmacokinetics, dosing principles and blood trough level monitoring of FK 506
    • Sewing KF 1994 Pharmacokinetics, dosing principles and blood trough level monitoring of FK 506. Transplant Proc 6: 3267-3269
    • (1994) Transplant. Proc. , vol.6 , pp. 3267-3269
    • Sewing, K.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.